Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections

(MedPage Today) -- MONTREAL -- For individuals infected by both HIV and hepatitis B virus (HBV), the choice of which virus-suppressing therapy to use can make a difference in outcomes, according to 48-week results of the phase III ALLIANCE results...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news